Aligos Therapeutics
ALGS
ALGS
45 hedge funds and large institutions have $23.9M invested in Aligos Therapeutics in 2023 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 11 increasing their positions, 10 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
5% less capital invested
Capital invested by funds: $25.3M → $23.9M (-$1.35M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
45
Holding in Top 10
1
Calls
$11K
Puts
–
Top Buyers
| 1 | +$874K | |
| 2 | +$552K | |
| 3 | +$532K | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$200K |
| 5 |
Morgan Stanley
New York
|
+$114K |
Top Sellers
| 1 | -$782K | |
| 2 | -$418K | |
| 3 | -$251K | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$219K |
| 5 |
Renaissance Technologies
New York
|
-$69.4K |